Is the prognosis of non‐hypertensive, COVID‐19 patients treated with renin–angiotensin–aldosterone system inhibitors more uncertain?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is the prognosis of non‐hypertensive, COVID‐19 patients treated with renin–angiotensin–aldosterone system inhibitors more uncertain?

Published:2022-11 Issue:22 Volume:10 Page:
ISSN:2051-817X
Container-title:Physiological Reports
language:en
Short-container-title:Physiological Reports

Author:

García Martínez Juan José¹²^ORCID,Wozniak Hannah²^ORCID,Salamin Pauline¹,Giraud Raphaël²³⁴^ORCID,Le Terrier Christophe²^ORCID,Bendjelid Karim²³⁴^ORCID

Affiliation:

1. Intensive Care Unit Hôpital du Valais Sion Switzerland

2. Intensive Care Division Geneva University Hospitals Geneva Switzerland

3. Geneva Hemodynamic Research Group Geneva Switzerland

4. Faculty of Medicine Geneva University Hospitals Geneva Switzerland

Publisher

Wiley

Subject

Physiology (medical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.14814/phy2.15512

Reference28 articles.

1. Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients

2. Pathophysiology of COVID-19: Everywhere You Look You Will See ACE2!

3. Angiotensin-converting enzyme 2 is an essential regulator of heart function

4. Role of Angiotensin II in Cardiovascular Disease — Therapeutic Implications of More Than a Century of Research

5. ACE2: more of Ang-(1–7) or less Ang II?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP